- Joined
- 6 September 2008
- Posts
- 7,676
- Reactions
- 68
I have a feeling this is where the money will be made in Australia in future, anyone know of shares/listed companies associated with medical research ?
Medical research stocks
- Thread starter MrBurns
- Start date
chops_a_must
Printing My Own Money
- Joined
- 1 November 2006
- Posts
- 4,636
- Reactions
- 3
Re: Medical Research
On what basis are you making these claims?
I would launch a counterpoint and say that threats to cut funding to research, higher education and post graduate study more than outweigh the potential in the short term.
On what basis are you making these claims?
I would launch a counterpoint and say that threats to cut funding to research, higher education and post graduate study more than outweigh the potential in the short term.
- Joined
- 6 September 2008
- Posts
- 7,676
- Reactions
- 68
Re: Medical Research
I'm thinking in the long term, mining has lost it's gloss we seem to be a forerunner in medical breakthroughs so I think that may be where our future lies..........we should be developing a "Silicon Valley" environment to encourage research.
I'm thinking in the long term, mining has lost it's gloss we seem to be a forerunner in medical breakthroughs so I think that may be where our future lies..........we should be developing a "Silicon Valley" environment to encourage research.
- Joined
- 30 June 2007
- Posts
- 7,200
- Reactions
- 1,225
Re: Medical Research
Biomed and alt energy are always worth a look when everything else is uninteresting...but only then. Such stocks tend to attract very quick, nervous money. A good way to trade them is to watch for a stock that has had say a 100%+ straight line run up over a few weeks, then wait for the 50% Fib retrace. Sell it at 38% retrace one or two days later.
Biomed and alt energy are always worth a look when everything else is uninteresting...but only then. Such stocks tend to attract very quick, nervous money. A good way to trade them is to watch for a stock that has had say a 100%+ straight line run up over a few weeks, then wait for the 50% Fib retrace. Sell it at 38% retrace one or two days later.
- Joined
- 6 September 2008
- Posts
- 7,676
- Reactions
- 68
Re: Medical Research
Thanks I guess it would be a speculative but I need to find one I think is smart and likely to do something worthwhile buy in then sit and wait.
Thanks I guess it would be a speculative but I need to find one I think is smart and likely to do something worthwhile buy in then sit and wait.
- Joined
- 30 June 2007
- Posts
- 7,200
- Reactions
- 1,225
Re: Medical Research
Quite a few good fundamentalists on HC - might be a good place to read? So few of the biomeds will avoid big pullbacks in their growth phase - that's the hard part for a long term trader. Even successes like MSB, big dips along the way.
Don't rule out the Fib pullback trade. It's very straight forward to find the set up and if you only had a dozen two-day trades in a whole year, you could do pretty well.
Quite a few good fundamentalists on HC - might be a good place to read? So few of the biomeds will avoid big pullbacks in their growth phase - that's the hard part for a long term trader. Even successes like MSB, big dips along the way.
Don't rule out the Fib pullback trade. It's very straight forward to find the set up and if you only had a dozen two-day trades in a whole year, you could do pretty well.
- Joined
- 2 June 2011
- Posts
- 5,341
- Reactions
- 242
Re: Medical Research
Have you seen the dips biotechs can take? If you get nervous when TLS falls 5-10% then you're going to be having a heart attack when some biotech falls 40-60% in a week on no news.
You really need to know what you're doing to start playing with those sort of stocks (and I mean know the technology they have, no what they can do with it, how big the market is, how strong the patents are etc, this requires original research as it won't be written about in the paper or in broker reports), or you will just be throwing good money down the drain. In 99% of cases they have no earnings, and often no revenue either.
Asymmetrical knowledge will be your biggest enemy, ie the guy on the other side of the trade will likely know more than you do.
Have you seen the dips biotechs can take? If you get nervous when TLS falls 5-10% then you're going to be having a heart attack when some biotech falls 40-60% in a week on no news.
You really need to know what you're doing to start playing with those sort of stocks (and I mean know the technology they have, no what they can do with it, how big the market is, how strong the patents are etc, this requires original research as it won't be written about in the paper or in broker reports), or you will just be throwing good money down the drain. In 99% of cases they have no earnings, and often no revenue either.
Asymmetrical knowledge will be your biggest enemy, ie the guy on the other side of the trade will likely know more than you do.
- Joined
- 6 September 2008
- Posts
- 7,676
- Reactions
- 68
pixel
DIY Trader
- Joined
- 3 February 2010
- Posts
- 5,359
- Reactions
- 344
It also pays to remain aware of legislative trends and court matters:
Human DNA not patentable: US Supreme Court
http://www.smh.com.au/technology/sc...tentable-us-supreme-court-20130614-2o7tx.html
This will certainly have an impact on the biotech sector. Maybe MSB's 5% slump today is an early reaction.
Human DNA not patentable: US Supreme Court
http://www.smh.com.au/technology/sc...tentable-us-supreme-court-20130614-2o7tx.html
This will certainly have an impact on the biotech sector. Maybe MSB's 5% slump today is an early reaction.
- Joined
- 6 September 2008
- Posts
- 7,676
- Reactions
- 68
prawn_86
Mod: Call me Dendrobranchiata
- Joined
- 23 May 2007
- Posts
- 6,637
- Reactions
- 7
As usual, i'm with McLovin on this one. Going from investing in TLS to a tiny biotech is a huge leap, especially with no previous industry knowledge.
Perhaps there is a biotech ETF that will diversify your risk? Have you looked into that?
Perhaps there is a biotech ETF that will diversify your risk? Have you looked into that?
- Joined
- 6 September 2008
- Posts
- 7,676
- Reactions
- 68
No but good thought.
- Joined
- 30 June 2007
- Posts
- 7,200
- Reactions
- 1,225
Sayce in his typical hyper red cordial mode. But there may be something here hidden amongst the junk.
http://pro.portphillippublishing.com.au/p06revtech1199/EBTPP610/
http://pro.portphillippublishing.com.au/p06revtech1199/EBTPP610/
- Joined
- 6 September 2008
- Posts
- 7,676
- Reactions
- 68
Unless you have expertise in the medical research field:
Fewer than 1 in 10 developed drugs are approved for human use, fewer than that make it to market.
The "market lifetime" of a successful new drug is ~10 years.
This means on the large end of the scale, you need to have a pipeline of drug R&D, with the creation of 1 successful new drug every year on average, to make it work.
It seems to cost anywhere between 4-12bn USD on average to create each new drug.
On the small end of the scale, 75% of startups fail.
Fewer than 1 in 10 developed drugs are approved for human use, fewer than that make it to market.
The "market lifetime" of a successful new drug is ~10 years.
This means on the large end of the scale, you need to have a pipeline of drug R&D, with the creation of 1 successful new drug every year on average, to make it work.
It seems to cost anywhere between 4-12bn USD on average to create each new drug.
On the small end of the scale, 75% of startups fail.
- Joined
- 6 September 2008
- Posts
- 7,676
- Reactions
- 68
Here in Oz we do seem to have more than our fair share of breakthroughs but that doesn't mean money, just more grants for research I guess.
Lol ... guess again ... I think Oz is one of the worst developed countries in terms of research to GDP ratios and it looks like things will get worse.
http://en.wikipedia.org/wiki/List_of_countries_by_research_and_development_spending
+1. The easier problems have been solved and the difficult ones are proving a bit too difficult and costly to pursue.
As an example in last few years a few drugs for Alzheimer's disease went through to stage 3 trials and failed. Cost of this through development was at a couple of billion dollars for each drug.
Subsequently most these drug companies have dramatically scaled back interest and funding in the area.
Purple XS2
Yamaha 650 XS2
- Joined
- 14 May 2007
- Posts
- 445
- Reactions
- 109
If by 'medical research' you include 'product (or technology) development', then there's plenty to choose from.
Rather than skew anybody's impression with my own arbitrary favourites (hint : look me up in the current and previous monthly stock-tipping contest), I'll suggest that a useful overview of the sector can be seen at http://www.biotechdaily.com.au/.
Public page has a month-by-month wrap. A subscriber newsletter can be obtained for a fee, and older copies can be accessed free.
But always be aware of the pitfalls: some of these bios crash and burn: check out the recent history of Pharmaxis (PXS) and Tissue Therapies (TIS), both of which I tried recently and both of which blew up in my face. And my old once-was-favourite, Avexa (AVX) which blew up in my face 3 years ago.
For hilarity, read the history of Genetic Technologies (GTG). You'll die laughing.
I have no medical/pharmaceutical background - but I try and learn the science in companies I look at, on the principle that a good idea, steered by reliable hands, is capable of explanation.
Biotech: if you're prepared to lose your shirt, that's when you'll appreciate all those hours you spent in the gym, metaphorically speaking.
Similar threads
